Nanochon, a Washington, DC-based company provider of solutions for sports medicine physicians, received an investment from cultivate(MD) Capital Funds.
The amount of the deal was not disclosed.
The company intends to use the funds to expand operations and its business reach.
Led by Benjamin Holmes, PhD, CEO, Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring cartilage restoration. Nanochon’s Chondrograft™ replaces lost or damaged cartilage and encourages new growth using an innovative material and 3D printed designs that are cost-effective and easy to deploy treatment options.
Commenting on the news, Benjamin Holmes said: “We at Nanochon are thrilled to welcome cultivate(MD) as a key investor and valued member of our Board of Directors. Their investment and board participation represent a significant vote of confidence in our vision and technology. This collaboration is a crucial step towards accelerating our groundbreaking work in revolutionizing joint health and regenerative treatments and will enable us to establish a new standard in minimally invasive, durable, and restorative treatments.”
FinSMEs
29/11/2023